betamethasone 1 MG/ML / clioquinol 30 MG/ML Topical Cream
- RxCUI
- 106243
- RxNorm name
- betamethasone 1 MG/ML / clioquinol 30 MG/ML Topical Cream
- Term type
- SCD
- Status
- Active
- Updated
- 2026-09-09 14:38:41
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Ingredient, Strength, Base table| Ingredient | Strength | Base | Basis of strength |
|---|
| betamethasone valerate | 1 MG / 1 ML | betamethasone | betamethasone valerate |
| clioquinol | 30 MG / 1 ML | clioquinol | clioquinol |
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | S02AA | Antiinfectives | ATC1-4 | | clioquinol |
| ATC | C05AA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S03BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S02BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | R01AD | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | betamethasone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | betamethasone |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | | betamethasone |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | | betamethasone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | betamethasone |
| ATC | R03BA | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | P01AA | Hydroxyquinoline derivatives | ATC1-4 | | clioquinol |
| ATC | D09AA | Medicated dressings with antiinfectives | ATC1-4 | | clioquinol |
| ATC | G01AC | Quinoline derivatives | ATC1-4 | | clioquinol |
| ATC | D08AH | Quinoline derivatives | ATC1-4 | | clioquinol |
| FDASPL | D000485 | Allergens | CHEM | has_chemical_structure | clioquinol |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000185508 | Standardized Chemical Allergen | EPC | has_epc | clioquinol |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| FDASPL | N0000184306 | Cell-mediated Immunity | PE | has_pe | clioquinol |
| FDASPL | N0000175629 | Increased Histamine Release | PE | has_pe | clioquinol |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D007464 | Clioquinol | CHEM | has_ingredient | clioquinol |
| MEDRT | D017486 | Acneiform Eruptions | DISEASE | may_treat | clioquinol |
| MEDRT | D003872 | Dermatitis | DISEASE | may_treat | clioquinol |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | clioquinol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005499 | Folliculitis | DISEASE | may_treat | clioquinol |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D017512 | Lichenoid Eruptions | DISEASE | may_treat | clioquinol |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D014008 | Tinea Pedis | DISEASE | may_treat | clioquinol |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | clioquinol |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009925 | Unknown Physiological Effect | PE | has_pe | clioquinol |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| CODES | SNOMEDCT | 331853004 |
| NAMES | Prescribable Synonym | betamethasone 0.1 % / clioquinol 3 % Topical Cream |
| SOURCES | Source | US Edition of SNOMED_CT |